Preferences of people with diabetes for diabetic retinopathy screening: A discrete choice experiment

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages 869-877

  Yeo, S T ^a   Edwards, R T ^a   Fargher, E A ^a   Luzio, S D ^b   Thomas, R L ^c   Owens, D R ^c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Diabetes; Diabetic retinopathy; Discrete choice experiment; Screening interval; Stated preference

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HEALTH SERVICE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; PREVALENCE; QUESTIONNAIRE; SCREENING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CHOICE BEHAVIOR; COMMUNICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT PREFERENCE; PILOT PROJECTS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; TIME FACTORS; TRAVEL; WALES; YOUNG ADULT;

EID: 84862659305     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03636.x     Document Type: Article

References (35)

1. Diabetes UK. Diabetes in the UK 2010: Key Statistics on Diabetes. March 2010. Available at Last accessed 18 June 2011.
2. Masso Gonzalez EL, Johansson S, Wallander M-A, Garcia Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63: 332-336.
3. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-2000. Eye 2008; 22: 905-911.
4. NICE. Clinical GuidelineE: Management of Type2 Diabetes-Retinopathy Screening and Early Management. February 2002. Available at Last accessed 18 June 2011.
5. Department of Health. Six Years on-Delivering the Diabetes National Service Framework. February 2010. Available at Last accessed 18 June 2011.
6. Welsh Assembly Government. National Service Framework for Diabetes in Wales- Delivery Strategy. March 2003. Available at Last accessed 18 June 2011.
7. Squirrell DM, Talbot JF. Screening for diabetic retinopathy. J R Soc Med 2003; 96: 273-276.
8. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type2 diabetes in the Liverpool Diabetic Eye study: a cohort study. Lancet 2003; 361: 195-200.
9. Misra A, Bachmann MO, Greenwood RH, Jenkins C, Shaw A, Barakat O et al. Trends in yield and effects of screening intervals during 17years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009; 26: 1040-1047.
10. Eye Care Wales. Screening for Diabetic Retinopathy. March 2009. Available at Last accessed 11 July 2011.
11. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type1 diabetes in a systematic screening programme. Diabet Med 2002; 20: 758-765.
12. Olafsdottir E, Stefansson E. Biennial eye screening in diabetic patients without retinopathy: 10-year experience. Br J Ophthalmol 2007; 91: 1599-1601.
13. Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type2 diabetic subjects without retinopathy. Diabetes Care 2011; 34: 1318-1319.
14. Thomas RL, Dunstan F, Luzio SD, Chowdury SR, Hale SL, North RV, Gibbins RL, Owens DR. Incidence of Diabetic Retinopahty in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. British Medical Journal 2012; 344: e874.
15. Department of Health. The New NHS: Modern, Dependable. London: The Stationery Office, 1997.
16. Department of Health. The NHS Plan-A Progress Report. March 2003. Available at Last accessed 18 June 2011.
17. Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5: 1-184.
18. Jones S, Edwards RT. Diabetic retinopathy screening: the economic evidence. Diabet Med 2009; 27: 249-256.
19. Sloane NJA. M.A.8.2.4.4.1. A Library of Orthogonal Arrays. November 2010. Available at Last accessed 18 June 2011.
20. Hall J, Viney R, Haas M, Louviere J. Using stated preference discrete choice modelling to evaluate health care programmes. J Bus Res 2004; 57: 1026-1032.
21. EuroQol. EQ-5D. User Guide Version 2. 2009. Available at Last accessed 19 June 2011.
22. Ryan M, Bate A, Eastmond C J, Ludbrook A. Use of discrete choice experiments to elicit preferences. Qual Health Care 2001; 10: i55-i60.
23. Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002; 37: 1681-1705.
24. Guimaraes C, Marra CA, Colley L, Gill S, Simpson S, Meneilly G et al. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type1 and type2 diabetes. Diabetes Technol Ther 2009; 11: 567-573.
25. Guimaraes C, Marra CA, Colley L, Gill S, Simpson SH, Meneilly GS et al. A valuation of patients' willingness-to-pay for insulin delivery in diabetes. Int J Technol Assess Health Care 2009; 25: 359-366.
26. Hauber AB, Mohamed AF, Johnson FR, Falvey H. Treatment preferences and medication adherence of people with Type2 diabetes using oral glucose-lowering agents. Diabet Med 2009; 26: 416-424.
27. Chen TT, Chung KP, Huang HC, Man LN, Lai MS. Using discrete choice experiment to elicit doctors' preferences for the report card design of diabetes care in Taiwan - a pilot study. J Eval Clin Pract 2010; 16: 14-20.
28. Nayaradou M, Berchi C, Dejardin O, Launoy G. Eliciting population preferences for mass colorectal cancer screening organization. Med Decis Mak 2010; 30: 224-233.
29. Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JD et al. Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer 2010; 102: 972-980.
30. van Dam L, Hol L, de Bekker-Grob EW, Steyerberg EW, Kuipers EJ, Habbema JD et al. What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2010; 46: 150-159.
31. Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK et al. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 2009; 18: 1420-1439.
32. Car J, Sheikh A. Email consultations in health care: 1-scope and effectiveness. Br Med J 2004; 329: 435-438.
33. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. York: Centre for Health Economics, 1999.
34. Secnik Boye K, Matza LS, Oglesby A, Malley K, Kim S, Hayes RP et al. Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type2 diabetes. Health Qual Life Outcomes 2006; 4: 80.
35. Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003; 2: 55-64.